Both EZH2 and JMJD6 regulate cell cycle genes in breast cancer
Abstract Background Strong evidences support the critical role of Jumonji domain containing 6 (JMJD6) in progression of breast cancer. Here we explore potential partners that coregulate gene expression, to understand additional pathways that are activated by higher amounts of JMJD6. Methods We used...
Main Authors: | Antara Biswas, Geetashree Mukherjee, Paturu Kondaiah, Kartiki V. Desai |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-11-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-020-07531-8 |
Similar Items
-
Systemic immune-inflammation index and ultrasonographic classification of breast imaging-reporting and data system predict outcomes of triple-negative breast cancer
by: Wang P, et al.
Published: (2019-01-01) -
Effect of N6-Methyladenosine Regulators on Progression and Prognosis of Triple-Negative Breast Cancer
by: Shanshan Wang, et al.
Published: (2021-01-01) -
Molecular Classification Models for Triple Negative Breast Cancer Subtype Using Machine Learning
by: Rassanee Bissanum, et al.
Published: (2021-09-01) -
Prognostic role of derived neutrophil-to-lymphocyte ratio in surgical triple-negative breast cancer
by: Ren K, et al.
Published: (2018-10-01) -
MicroRNA-223 is Associated with Resistance Towards Platinum-based Chemotherapy and Worse Prognosis in Indonesian Triple-negative Breast Cancer Patients
by: Purwanto I, et al.
Published: (2021-01-01)